These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16518421)

  • 1. Iron-overload in long-term survivors of hematopoietic transplantation.
    Kamble R; Mims M
    Bone Marrow Transplant; 2006 Apr; 37(8):805-6. PubMed ID: 16518421
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
    Kim YR; Kim JS; Cheong JW; Song JW; Min YH
    Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron overload in hematopoietic cell transplantation.
    Majhail NS; Lazarus HM; Burns LJ
    Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
    Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W
    Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
    Majhail NS; DeFor T; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-overload after autologous hematopoietic cell transplantation.
    Majhail NS; DeFor TE; Lazarus HM; Burns LJ
    Leuk Res; 2009 Apr; 33(4):578-9. PubMed ID: 18632150
    [No Abstract]   [Full Text] [Related]  

  • 7. Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation.
    Koreth J; Antin JH
    Haematologica; 2010 Mar; 95(3):364-6. PubMed ID: 20207843
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
    Pullarkat V; Blanchard S; Tegtmeier B; Dagis A; Patane K; Ito J; Forman SJ
    Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies.
    Park IH; Kim Y; Kim JS; Cheong JW; Song JW; Min YH
    Transfus Med; 2008 Apr; 18(2):97-103. PubMed ID: 18399843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation.
    Brissot E; Savani BN; Mohty M
    Semin Hematol; 2012 Jan; 49(1):35-42. PubMed ID: 22221783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress.
    Evens AM; Mehta J; Gordon LI
    Bone Marrow Transplant; 2004 Oct; 34(7):561-71. PubMed ID: 15286699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of intrahepatic iron deposition in transfusion-dependent iron overload patients with hematological malignancies.
    Kobayashi H; Yoshimura N; Uemura S; Katagiri T; Tanaka T; Ushiki T; Fuse K; Shibasaki Y; Narita M; Sone H; Masuko M
    Leuk Res; 2018 Jul; 70():41-44. PubMed ID: 29803982
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
    Malcovati L
    Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Overload in Survivors of Childhood Cancer.
    Schempp A; Lee J; Kearney S; Mulrooney DA; Smith AR
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):27-31. PubMed ID: 26422286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
    Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
    Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
    Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of iron in patients after bone marrow transplantation.
    de Witte T
    Blood Rev; 2008 Dec; 22 Suppl 2():S22-8. PubMed ID: 19059053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies.
    Leitch HA; Fibach E; Rachmilewitz E
    Crit Rev Oncol Hematol; 2017 May; 113():156-170. PubMed ID: 28427505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.